127 related articles for article (PubMed ID: 26040073)
1. Use of serum levels of proinflammatory cytokine IL-1α in chronic hepatitis C.
Vanis N; Mehmedović A; Mesihović R
Coll Antropol; 2015 Mar; 39(1):75-9. PubMed ID: 26040073
[TBL] [Abstract][Full Text] [Related]
2. Use of serum levels of proinflammatory cytokine IL-1alpha in chronic hepatitis B.
Vukobrat-Bijedic Z; Mehmedovic A; Redzepovic A; Gogov B
Med Arch; 2014; 68(2):94-7. PubMed ID: 24937930
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive liver fibrosis markers: use of serum levels of cytokines IL 1α and TGF ß1 in management of chronic liver diseases.
Mehmedović A; Mesihović R; Prnjavorac B; Vanis N; Vukobrat-Bijedić Z; Borovac N; Zubčević N; Pilav A; Gornjaković S; Kulo-Ćesić A; Mujarić E; Saray A
Med Glas (Zenica); 2013 Feb; 10(1):20-7. PubMed ID: 23348156
[TBL] [Abstract][Full Text] [Related]
4. Impact of Schistosoma mansoni co-infection on serum profile of interferon-gamma, interleukin-4 and interleukin-10 in patients with chronic hepatitis C virus infection.
Emam EA; Emam M; Shehata AE; Emara M
Egypt J Immunol; 2006; 13(2):33-40. PubMed ID: 18689269
[TBL] [Abstract][Full Text] [Related]
5. Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C.
Falasca K; Ucciferri C; Dalessandro M; Zingariello P; Mancino P; Petrarca C; Pizzigallo E; Conti P; Vecchiet J
Ann Clin Lab Sci; 2006; 36(2):144-50. PubMed ID: 16682509
[TBL] [Abstract][Full Text] [Related]
6. IL-1α correlates with severity of hepatitis C virus-related liver diseases.
Tawfik AK; Amin AM; Yousef M; El-Sayd NM; Elashry H; Elkadeem M; Abd-Elsalam S
J Inflamm Res; 2018; 11():289-295. PubMed ID: 30022847
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of Th17 associated cytokines in chronic hepatitis C virus infection.
Sousa GM; Oliveira IS; Andrade LJ; Sousa-Atta ML; Paraná R; Atta AM
Cytokine; 2012 Oct; 60(1):138-42. PubMed ID: 22748467
[TBL] [Abstract][Full Text] [Related]
8. Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients.
Shahid M; Idrees M; Nasir B; Raja AJ; Raza SM; Amin I; Rasul A; Tayyab GU
Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):788-94. PubMed ID: 24781355
[TBL] [Abstract][Full Text] [Related]
9. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
[TBL] [Abstract][Full Text] [Related]
10. Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection.
Reiser M; Marousis CG; Nelson DR; Lauer G; González-Peralta RP; Davis GL; Lau JY
J Hepatol; 1997 Mar; 26(3):471-8. PubMed ID: 9075651
[TBL] [Abstract][Full Text] [Related]
11. Influence of HCV infection on insulin-like growth factor 1 and proinflammatory cytokines: association with risk for growth hormone resistance development.
Helaly GF; El-Afandy NM
Egypt J Immunol; 2009; 16(2):115-24. PubMed ID: 22059359
[TBL] [Abstract][Full Text] [Related]
12. Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease.
Gigi E; Raptopoulou-Gigi M; Kalogeridis A; Masiou S; Orphanou E; Vrettou E; Lalla TH; Sinakos E; Tsapas V
J Viral Hepat; 2008 Feb; 15(2):145-54. PubMed ID: 18184198
[TBL] [Abstract][Full Text] [Related]
13. Cytokine profiles and hepatic injury in occult hepatitis C versus chronic hepatitis C virus infection.
Mousa N; Eldars W; Eldegla H; Fouda O; Gad Y; Abousamra N; Elmasry E; Arafa M
Int J Immunopathol Pharmacol; 2014; 27(1):87-96. PubMed ID: 24674682
[TBL] [Abstract][Full Text] [Related]
14. An immunosuppressive function of interleukin-35 in chronic hepatitis C virus infection.
Liu S; Zhang Q; Shao X; Wang W; Zhang C; Jin Z
Int Immunopharmacol; 2017 Sep; 50():87-94. PubMed ID: 28644966
[TBL] [Abstract][Full Text] [Related]
15. Genotype-related variations in proinflammatory and regulatory cytokine levels in treated and treatment-naive HCV-infected patients.
Baharlou R; Romani B; Kiani SJ; Sadeghi K; Shadmand E; Fazel H; Jalilian FA; Kord E; Yaghoubi S; Nikmanesh Y; Ahmadi Vasmehjani A
Med Microbiol Immunol; 2018 Feb; 207(1):65-74. PubMed ID: 29147974
[TBL] [Abstract][Full Text] [Related]
16. Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection.
McGuinness PH; Painter D; Davies S; McCaughan GW
Gut; 2000 Feb; 46(2):260-9. PubMed ID: 10644323
[TBL] [Abstract][Full Text] [Related]
17. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
18. Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance.
Helaly GF; Hussein NG; Refai W; Ibrahim M
Transl Res; 2011 Sep; 158(3):155-62. PubMed ID: 21867981
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.
Moschen AR; Fritz T; Clouston AD; Rebhan I; Bauhofer O; Barrie HD; Powell EE; Kim SH; Dinarello CA; Bartenschlager R; Jonsson JR; Tilg H
Hepatology; 2011 Jun; 53(6):1819-29. PubMed ID: 21381070
[TBL] [Abstract][Full Text] [Related]
20. Cytokine levels and histopathology in chronic hepatitis B and chronic hepatitis C.
Akcam FZ; Tigli A; Kaya O; Ciris M; Vural H
J Interferon Cytokine Res; 2012 Dec; 32(12):570-4. PubMed ID: 23067363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
